Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT01649804
Eligibility Criteria:
Inclusion Criteria:
* Adult participants, \>/=18 years of age who have completed the core study WA19926 and according to the investigator may benefit from RoActemra/Actemra treatment
* No current or recent adverse event or laboratory finding preventing the use of the study drug dose at baseline
* Receiving treatment on an outpatient basis
Exclusion Criteria:
* Females who are pregnant
* Participants who have prematurely withdrawn from the core study WA19926 for any reason
* Treatment with any investigational drug since the last administration of the study drug in the core study WA19926
* Treatment with an anti-tumor necrosis (TNF), anti-interleukin 1 agent or T-cell costimulation modulator since the last administration of the study drug in the core study WA19926
* Immunization with live/attenuated vaccine since the last administration of the study drug in the core study WA19926
* Diagnosis since the last WA19926 visit of rheumatic autoimmune disease or inflammatory joint disease other than rheumatoid arthritis
* Abnormal laboratory values
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01649804
Study Brief:
Protocol Section:
NCT01649804